Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative.
Journal
Pediatric quality & safety
ISSN: 2472-0054
Titre abrégé: Pediatr Qual Saf
Pays: United States
ID NLM: 101702480
Informations de publication
Date de publication:
Historique:
received:
26
05
2020
accepted:
02
09
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
8
1
2021
Statut:
epublish
Résumé
Sickle cell disease is a complex chronic disorder associated with increased morbidity and early mortality. The Pediatric Quality Measures Program has developed new sickle cell-specific quality measures focused on hydroxyurea (HU) counseling and annual transcranial Doppler (TCD) screening; however, these measures have not been used in a clinical setting to inform quality improvement (QI) efforts. From 2017 to 2018, 9 sickle cell subspecialty clinics from the Pacific Sickle Cell Regional Collaborative conducted a year-long QI collaborative focused on improving the percentage of patients with HU counseling and TCD screening based on the new quality measures. After an initial kick-off meeting, the 9 sites participated in monthly conference calls. We used run charts annotated with plan-do-study-act cycle activities to track each site's monthly progress and the overall mean percentage for the entire collaborative. There was an overall improvement in the aggregate HU counseling from 85% to 98% ( Over 1 year, we found that a regional QI collaborative increased HU counseling. Although referral for TCD screening increased, there was no overall change in TCD completion. Overall, this QI report's findings can help clinicians adopt and implement these quality measures to improve outcomes in children.
Identifiants
pubmed: 33409431
doi: 10.1097/pq9.0000000000000379
pmc: PMC7781296
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e379Informations de copyright
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no financial interest to declare in relation to the content of this article.
Références
Clin Pediatr (Phila). 2015 Apr;54(4):336-45
pubmed: 25320061
Blood. 2006 Aug 1;108(3):847-52
pubmed: 16861341
JAMA Pediatr. 2016 Jun 1;170(6):550-6
pubmed: 27064406
J Healthc Qual. 2009 Jul-Aug;31(4):43-52; quiz 52-3
pubmed: 19753808
Pediatrics. 2017 Jan;139(1):
pubmed: 28025242
Ann Surg. 2010 Jan;251(1):165-70
pubmed: 20009752
BMJ Open Qual. 2017 Oct 21;6(2):e000084
pubmed: 29209663
J Community Health. 2017 Feb;42(1):66-71
pubmed: 27476162
J Contin Educ Health Prof. 2016 Summer;36 Suppl 1:S48-9
pubmed: 27584072
Health Serv Res. 2009 Apr;44(2 Pt 1):359-78
pubmed: 19040423
Nat Rev Dis Primers. 2018 Mar 15;4:18010
pubmed: 29542687
Cochrane Database Syst Rev. 2017 Apr 20;4:CD002202
pubmed: 28426137
Pediatr Blood Cancer. 2019 Jun;66(6):e27721
pubmed: 30900800